LumiraDx Limited offers a platform that supports various tests with lab comparable performance at the point of care. The company has 30 tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. LumiraDx was founded in 2014 and is headquartered in London, UK.
What is Lumiradx's quote symbol?
What is the 52 week high and low for Lumiradx (NASDAQ: LMDX)?
How much is Lumiradx stock worth today?
How much is Lumiradx's stock price per share?
What is Lumiradx's Market Cap?